Focal Radiation With Pulsed Systemic Therapy of Abiraterone, ADT, Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON): A Phase II, Single Arm, Single Institution Study
Latest Information Update: 26 Mar 2026
At a glance
- Drugs Abiraterone acetate (Primary) ; Olaparib (Primary) ; Prednisone (Primary) ; LHRH receptor agonists; LHRH receptor antagonists
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms FAALCON
Most Recent Events
- 06 Mar 2026 Planned End Date changed from 1 Dec 2025 to 1 May 2026.
- 06 Mar 2026 Planned primary completion date changed from 1 Dec 2025 to 1 May 2026.
- 02 Apr 2025 Planned End Date changed from 1 May 2025 to 1 Dec 2025.